Please assess the completion status of the following clinical trial:

Trial Title: High-Volume Plasma Exchange Versus Standard Medical Treatment in Patients With Acute Liver Failure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with acute liver failure defined as : Patients with jaundice which is complicated by encephalopathy and coagulopathy within 4 weeks of the onset of jaundice and without underlying chronic liver disease.~Exclusion Criteria:~* Age \<12 or \> 75 years~* Hepato-Cellular Carcinoma~* Active untreated Sepsis/DIC~* Any evidence of active bleed secondary to coagulopathy~* Hemodynamic instability requiring high dose of Vasopressors~* Coma of non-hepatic origin.~* Pregnancy~* Comorbidities associated with poor outcome (Extrahepatic neoplasia, severe cardiopulmonary disease defined by a New York Heart Association score \>3, or oxygen/steroid-dependent chronic obstructive pulmonary disease).~* Patients being taken up for liver transplant~* Refusal to participate in the study.

- Gender: ALL
- Minimum Age: 12 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Standard medical therapy with Plasma Exchange (Type: EXPERIMENTAL): Plasma Exchange will be performed for consecutive days. Standard medical therapy included as per requirement,management of cerebral edema/intracranial hypertension: transfer to ICU,prophylactic antibiotics, intubation of trachea (as required),administration of mannitol or 3% saline for severe elevation of Intra Cranial Pressure,volume replacement and pressor support (norepinephrine, vasopressin) as needed, NAC, correction of metabolic parameters and nutrition.
- Standard medical therapy alone (Type: ACTIVE_COMPARATOR): Standard medical therapy included as per requirement,management of cerebral edema/intracranial hypertension: transfer to ICU,prophylactic antibiotics, intubation of trachea (as required),administration of mannitol or 3% saline for severe elevation of Intra Cranial Pressure,volume replacement and pressor support (norepinephrine, vasopressin) as needed, NAC, correction of metabolic parameters and nutrition.

Based on this trial design, predict the completion outcome and termination type (if applicable).